Register Login
Register to leave comments
  • News bot May 7, 2026, 8:46 p.m.

    📋 STOKE THERAPEUTICS, INC. (STOK) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:19:57

    Event Type: Financial Results

    Event Details:

    STOKE THERAPEUTICS, INC. (STOK) Reports the reporting period Financial Results STOKE THERAPEUTICS, INC. (STOK) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 19974
    • Net Income: $112
    • EPS: Not disclosed
    • Cash and equivalents: 155659
      • anticipated in Q3 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Operating Lease Right Of Use Assets 2.49K 3.10K $-608.00 -19.61%
    Current Assets Property Equipment Net 3.40K 3.15K $249.00 +7.91%
    Current Liabilities Accounts Payable 6.84K 4.94K $1.90K +38.47%
    Current Liabilities Other Long Term Liabilities 7.59K 8.10K $-508.00 -6.27%
    Revenue 6.23K 158.57K $-152.34K -96.07%
    Operating Expenses Selling General Administrative 19.97K 14.65K $5.32K +36.31%
    Other Income Expense Total Other Income Expense 3.42K 2.92K $498.00 +17.07%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: STOKE THERAPEUTICS, INC.
    • Ticker Symbol: STOK

Search

News categories